MedTrace Logo

Ketamine Enhances Analgesia and Mood in Chronic Pain Patients

NCT05985811 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-01-27

No results posted yet for this study

Summary

Most chronic pain patients have mood disorders. The mood disorders may improve with better analgesia produced by Ketamine injections. A prospective study of patients undergoing interventional pain therapy using Ketamine injections. Pre-injection and post-injection patient data is collected. Pain is measured using numeric pain rating scale, and change in pain score by 2-points is considered significant. Sleep is measured using Likert sleep scale, and change in sleep score by 2-points is considered significant. Anxiety is measured using general anxiety disorder (GAD-7) scale, and change in anxiety score by 4-points is considered significant. Depression is measured using patient health questionnaire (PHQ-9), and change in depression score by 5-points is considered significant.

Conditions

  • Mood Disorder; Opioid
  • Mood Insomnia

Sponsors & Collaborators

  • Salem Anaesthesia Pain Clinic

    lead OTHER

Principal Investigators

  • Olumuyiwa Bamgbade, MD,FRCPC · Salem Anaesthesia Pain Clinic

Eligibility

Min Age
20 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-02
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05985811 on ClinicalTrials.gov